Evidence map›Paper›PMID 27186236›Full record

ArticleChemistry Central journal2016

Optimization and in vitro antiproliferation of Curcuma wenyujin's active extracts by ultrasonication and response surface methodology.

Xiaoqin Wang, Ying Jiang, Daode Hu

Abstract read
In one paragraph

Article in Chemistry Central journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiaoqin WangDepartment of Clinical Pharmacology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080 China.
Ying JiangDepartment of Clinical Pharmacology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080 China.
Daode HuDepartment of Clinical Pharmacology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 100 Haining Road, Shanghai, 200080 China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurcuma wenyujin, a member of the genus Curcuma, has been widely prescribed for anti-cancer therapy. Multiple response surface optimization has attracted a great attention, while, the research about optimizing three or more responses employing response surface methodology (RSM) was very few.

resultsRSM and desirability function (DF) were employed to get the optimum ultrasonic extraction parameters, in which the extraction yields of curdione, furanodienone, curcumol and germacrone from C. wenyujin were maximum. The yields in the extract were accurately quantified using the validated high performance liquid chromatography method with a good precision and accuracy. The optimization results indicated that the maximum combined desirability 97.1 % was achieved at conditions as follows: liquid-solid ratio, 8 mL g(-1); ethanol concentration, 70 % and ultrasonic time, 20 min. The extraction yields gained from three verification experiments were in fine agreement with those of the model's predictions. The surface morphologies of the sonication-treated C. wenyujin were loose and rough. The extract of C. wenyujin presented obvious antiproliferative activities against RKO and HT-29 cells in vitro.

conclusionResponse surface methodology was successfully applied to model and optimize the ultrasonic extraction of four bioactive components from C. wenyujin for antiproliferative activitiy.Graphical abstract.

Indexed as

Antiproliferative activityCurcuma wenyujinHigh performance liquid chromatographyResponse surface methodologyUltrasonic extraction

Identifiers

PMID27186236
PMCPMC4868111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.